Mercer Global Advisors
DNA icon

Mercer Global Advisors’s Ginkgo Bioworks DNA Stock Holding History

Mercer Global Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,836
Closed -$116K – 2181
2024
Q4 		$116K Buy
+11,836
New +$101K ﹤0.01% 2022
2024
Q3 		– Sell
-1,375
Closed -$18.4K – 1977
2024
Q2 		$18.4K Sell
1,375
-2,796
-67% -$83.4K ﹤0.01% 1951
2024
Q1 		$194K Buy
4,171
+703
+20% +$36.4K ﹤0.01% 1792
2023
Q4 		$234K Sell
3,468
-2,076
-37% -$127K ﹤0.01% 1751
2023
Q3 		$401K Buy
5,544
+3,042
+122% +$243K ﹤0.01% 1363
2023
Q2 		$186K Buy
2,502
+2,122
+558% +$126K ﹤0.01% 1751
2023
Q1 		$20K Sell
380
-77
-17% -$4.88K ﹤0.01% 1898
2022
Q4 		$31K Buy
457
+145
+46% +$13.3K ﹤0.01% 1889
2022
Q3 		$39K Buy
312
+58
+23% +$6.91K ﹤0.01% 1781
2022
Q2 		$24K Buy
+254
New +$31K ﹤0.01% 1793

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return